CClinicalTrials.gg
CompletedNCT06366295Updated Jul 24, 2026

Comparison of Subgingival Mechanotherapy With and Without the Use of a Perioscope: Clinical Trial

An interventional study of subgingival mechanotherapy with perioscopy and classical subgingival mechanotherapy in Periodontitis, sponsored by Medical University of Warsaw. Completed at 1 site in Poland. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Medical University of Warsaw · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jun 2023, registered Apr 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The study aims to comparatively assess clinical parameters, biochemical and microbiological parameters after treatment of periodontitis using subgingival mechanotherapy traditional and subgingival mechanotherapy using a perioscope.

Read the detailed description

Non-surgical treatment is the basic form of disease treatment periodontitis. Its first stage is the mechanical removal of dental plaque along with the control of risk factors. Subgingival mechanotherapy, also known as scaling and root planing (SRP) is the next stage, aimed at the subgingival area. Perioscopy makes possible direct real-time visualization of the root surface during the procedure. The research results published so far indicate improvement or no significant differences clinical parameters after SRP procedure using a perioscope vs traditional subgingival instrumentation. The aim of this study is to indicate, or not, clinical, biochemical (level of pro-inflammatory cytokines) and microbiological (A. actinomycetemcomitans, P. gingivalis, T. denticola) differences after periodontitis treatment using the traditional method vs. using a perioscope.

02

Conditions studied

  • Periodontitis

Browse trials for

Keywords

  • periodontal endoscopy, perioscopy
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 26 is below the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Medical University of Warsaw is the lead sponsor of 316 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 20-60; (II)
  • preserved lateral and anterior teeth;
  • no periodontal treatment in the last 12 months;
  • intermediate or advanced periodontitis (Stage II / III / IV)
  • in each quadrant at least three teeth with PPD>5 mm after initial treatment (scaling, motivation, instruction)

Exclusion criteria

Exclusion Criteria:

  • antibiotic therapy in the last 6 months;
  • smoking;
  • systemic diseases affecting periodontal tissues;
  • pregnancy or lactation;
  • orthodontic treatment;
  • tooth mobility II / III degree;
  • involvement of third degree furcations according to Hamp classification;
  • endodontic issues
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Subgingival mechanotherapy with perioscopy

    Scaling and root planing using ultrasonic scaler and curettes, under the control of a perioscope, enabling real-time, magnified imaging of the root surface.

    Device: subgingival mechanotherapy with perioscopy

  • Active comparator
    Classical subgingival mechanotherapy

    Scaling and root planing using ultrasonic scaler and curettes.

    Device: classical subgingival mechanotherapy

Interventions

  • Devicesubgingival mechanotherapy with perioscopy

    Subgingival mechanotherapy using a machine scaler, curettes and a perioscope

  • Deviceclassical subgingival mechanotherapy

    Subgingival mechanotherapy using a machine scaler and curettes

06

What researchers measure

Primary outcomes

  1. Probing pocket depth (PPD)

    Distance from the gingival margin to the bottom of the gingival sulcus

    Time frame: 0 (before), 3 and 6 months after SRP

  2. Clinical attachment level (CAL)

    Distance from the cementoenamel junction to the bottom of the gingival sulcus

    Time frame: 0 (before), 3 and 6 months after SRP

  3. Bleeding on probing (BoP)

    Percentage of sites with bleeding provoked by applying a probe to the bottom of a sulcus/pocket.

    Time frame: 0 (before), 3 and 6 months after SRP

  4. Plaque index (PI)

    Percentage of sites with plaque

    Time frame: 0 (before), 3 and 6 months after SRP

Secondary outcomes

  1. Width of keratinized tissue (KTW)

    Distance between the most apical point of gingival margin and the mucogingival junction

    Time frame: 0 (before), 3 and 6 months after SRP

  2. Gingival thickness (GT)

    Thickness of the gingiva measured 2 mm apical to the gingival margin

    Time frame: 0 (before), 3 and 6 months after SRP

Other outcomes

  1. Subgingival plaque pathogens (Aa, Pg, Td) levels

    Levels of periodontal pathogens (Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Treponema denticola) measured with real-time polymerase chain reaction (RT-PCR) test; data presented as number of bacteria of these species and percentage of total bacteria found in a sample; sample taken from the deepest pocket on each side.

    Time frame: 0 (before) and 6 months after SRP

  2. Gingival crevicular fluid levels of cytokines

    Levels of (IL - interleukin) IL-1β, IL-6, IL-8, IL-10 and interferon-gamma in gingival crevicular fluid presented as pg/ml; sample taken from the deepest pocket on each side.

    Time frame: 0 (before), 3 and 6 months after SRP

07

Study locations

1 site
  • Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw
    Warsaw, Masovian Voivodeship 02-097, Poland
08

References and documents

Study documents

  • Study protocol · Apr 10, 2024

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06366295
Lead sponsor
Medical University of Warsaw
Responsible party
Sponsor
First posted
Apr 15, 2024
Start date
Jun 1, 2023
Primary completion
Jan 31, 2026
Completion
Jan 31, 2026
Last update
Jul 24, 2026

Study contacts

Bartlomiej Górski, PhD
principal investigator · Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion